Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$841128.0.

  • HeartSciences' Net Cash Flow fell 19240.56% to -$841128.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$2.1 million, marking a year-over-year decrease of 15316.37%. This contributed to the annual value of -$4.7 million for FY2025, which is 21356.03% down from last year.
  • According to the latest figures from Q4 2025, HeartSciences' Net Cash Flow is -$841128.0, which was down 19240.56% from $1.7 million recorded in Q3 2025.
  • Over the past 5 years, HeartSciences' Net Cash Flow peaked at $7.0 million during Q1 2024, and registered a low of -$1.5 million during Q2 2025.
  • Over the past 5 years, HeartSciences' median Net Cash Flow value was -$742772.0 (recorded in 2021), while the average stood at $5287.8.
  • Data for HeartSciences' Net Cash Flow shows a peak YoY increase of 70928.1% (in 2024) and a maximum YoY decrease of 36910.14% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows HeartSciences' Net Cash Flow stood at -$768053.0 in 2021, then crashed by 55.79% to -$1.2 million in 2022, then soared by 60.26% to -$475510.0 in 2023, then surged by 39.51% to -$287658.0 in 2024, then tumbled by 192.41% to -$841128.0 in 2025.
  • Its last three reported values are -$841128.0 in Q4 2025, $1.7 million for Q3 2025, and -$1.5 million during Q2 2025.